Nurix Therapeutics Inc. (NRIX): Price and Financial Metrics
NRIX Price/Volume Stats
| Current price | $9.56 | 52-week high | $29.56 |
| Prev. close | $9.46 | 52-week low | $8.18 |
| Day low | $9.33 | Volume | 437,800 |
| Day high | $9.69 | Avg. volume | 878,027 |
| 50-day MA | $11.31 | Dividend yield | N/A |
| 200-day MA | $19.07 | Market Cap | 728.82M |
NRIX Stock Price Chart Interactive Chart >
Nurix Therapeutics Inc. (NRIX) Company Bio
Nurix Therapeutics, Inc. is a biopharmaceutical company. It focuses on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company was founded by John Kuriyan, Michael Rapé, and Arthur Weiss in 2009 and is headquartered in San Francisco, CA.
NRIX Price Returns
| 1-mo | -6.64% |
| 3-mo | -45.65% |
| 6-mo | -56.13% |
| 1-year | -42.37% |
| 3-year | -4.50% |
| 5-year | N/A |
| YTD | -49.26% |
| 2024 | 82.56% |
| 2023 | -6.01% |
| 2022 | -62.07% |
| 2021 | -11.95% |
| 2020 | N/A |
Loading social stream, please wait...